Deacetylclivorine: A Gender-Selective Metabolite of Clivorine Formed in Female Sprague-Dawley Rat Liver Microsomes
Authors:
- Ge LinGLGe Lin
- Jun TangJTJun Tang
- Xiao Quan LiuXLXiao Quan Liu
- Yan JiangYJYan Jiang
- Jiang ZhengJZJiang Zheng
Open Access
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 35 (4) , 607-613
Abstract
Clivorine, a naturally occurring pyrrolizidine alkaloid, causes liver toxicity via its metabolic activation to generate toxic metabolite (pyrrolic ester). Female Sprague-Dawley (SD) rats are reported to be less susceptible to clivorine intoxication than male SD rats. However, the biochemical mechanism causing such gender difference is largely unknown. The present study investigated hepatic microsomal metabolism of clivorine in female rats to delineate the mechanism of the gender difference. Two pathways, which directly metabolize clivorine, were observed. First, the metabolic activation to produce the toxic pyrrolic ester followed by formations of bound pyrroles, dehydroretronecine, 7-glutathionyldehydroretronecine, and clivoric acid were found in female rats, and CYP3A1/2 isozymes were identified to catalyze the metabolic activation. Compared with male rats (∼21%), the metabolic activation in female rats was significantly lower (∼4%) possibly because of significantly lower CYP3A1/2 levels expressed in female rats. Second, a direct hydrolysis to generate the novel female rat-specific metabolite deacetylclivorine was shown as the predominant pathway (∼16% clivorine metabolism) in female rat liver microsomes and was determined to be mediated by microsomal hydrolase A. Furthermore, when the metabolic activation was completely inhibited by ketoconazole, the amount of deacetylclivorine formed in a 1-h incubation significantly increased from 19.44 ± 3.00 to 54.87 ± 9.30 nmol/mg protein, suggesting that the two pathways compete with each other. Therefore, the lower susceptibility of female SD rats to clivorine intoxication is suggested to be caused by the significantly higher extent of the direct hydrolysis and a lower degree of the metabolic activation.Keywords
This publication has 33 references indexed in Scilit:
- Pyrrolizidine Alkaloids—Genotoxicity, Metabolism Enzymes, Metabolic Activation, and MechanismsDrug Metabolism Reviews, 2004
- Constitutive and Inducible Hepatic Cytochrome P450 Isoforms in Senescent Male and Female Rats and Response to Low-Dose PhenobarbitalDrug Metabolism and Disposition, 2003
- Genotoxic Pyrrolizidine Alkaloids — Mechanisms Leading to DNA Adduct Formation and TumorigenicityInternational Journal of Molecular Sciences, 2002
- Involvement of Liver Carboxylesterases in the In Vitro Metabolism of LidocaineDrug Metabolism and Disposition, 2002
- Simultaneous analysis of clivorine and its four microsomal metabolites by high-performance liquid chromatographyJournal of Chromatography A, 2000
- The Roles of CYP3A and CYP2B Isoforms in Hepatic Bioactivation and Detoxification of the Pyrrolizidine Alkaloid Senecionine in Sheep and HamstersToxicology and Applied Pharmacology, 1998
- Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomesBritish Journal of Clinical Pharmacology, 1998
- Effects of testosterone and estrogen on hepatic levels of cytochromes P450 2C7 and P450 2C11 in the ratArchives of Biochemistry and Biophysics, 1992
- Mechanisms for Pyrrolizidine Alkaloid Activation and Detoxification1991
- Activation and pulmonary toxicity of pyrrolizidine alkaloidsPharmacology & Therapeutics, 1990